All Routine PSA Tests For Prostate Cancer Should End, Task Force Says

[unc70]

12. About biopsy, there is research

A prostate biopsy (usually 12 samples) can give a lot of information and help determine the best course of treatment for a given patient. But it has limits. We know far less about types of prostate cancers than we do for many others like breast cancer.

Johns Hopkins has been studying watchful waiting following biopsy for patients with certain characteristics considered lower risk. It is too early to be sure about outcomes. This is not the same as not screening.

Another study showed that significantly better 10-year survival rates for those with surgery.

Since PSA screening is only been around for about 20 years and nerve conserving surgery became widely available even later, things are quite the muddle.